Dobrică, E.-C.; Găman, M.-A.; Cozma, M.-A.; Bratu, O.G.; Pantea Stoian, A.; Diaconu, C.C.
Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department. Medicina 2019, 55, 436.
https://doi.org/10.3390/medicina55080436
AMA Style
Dobrică E-C, Găman M-A, Cozma M-A, Bratu OG, Pantea Stoian A, Diaconu CC.
Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department. Medicina. 2019; 55(8):436.
https://doi.org/10.3390/medicina55080436
Chicago/Turabian Style
Dobrică, Elena-Codruța, Mihnea-Alexandru Găman, Matei-Alexandru Cozma, Ovidiu Gabriel Bratu, Anca Pantea Stoian, and Camelia Cristina Diaconu.
2019. "Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department" Medicina 55, no. 8: 436.
https://doi.org/10.3390/medicina55080436
APA Style
Dobrică, E.-C., Găman, M.-A., Cozma, M.-A., Bratu, O. G., Pantea Stoian, A., & Diaconu, C. C.
(2019). Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department. Medicina, 55(8), 436.
https://doi.org/10.3390/medicina55080436